TrialMedical oncology (Northwood, London, England)2025

Addition of thalidomide for prevention of chemotherapy-induced nausea and vomiting in the second cycle after the failure of four-drug regimen in the first cycle.

Nishil Gowda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.